Format

Send to

Choose Destination
Mol Immunol. 2011 Jun;48(11):1344-7. doi: 10.1016/j.molimm.2010.11.021. Epub 2010 Dec 30.

B cell immunotherapy in autoimmunity--2010 update.

Author information

1
Department of Immunology, Genentech, Inc., One DNA Way, MS-34, Building 11-215, South San Francisco, CA 94080, USA. acc@gene.com

Abstract

B cells play important roles in normal immunity and human disease. While much has been learned from elegant studies utilizing genetically modified mice or with immunotherapy in normal and in autoimmune mice, we are merely at the start of learning about the mechanism(s) by which B cells contribute to human autoimmune disease. Here, I will review the most recent insights obtained with immunomodulatory therapies in human disease highlighting the clinical and immunological lessons we have learned with B cell depleting (e.g., rituximab) and immunomodulatory (e.g., BAFF/BLys neutralization through belimumab) therapies.

PMID:
21194752
DOI:
10.1016/j.molimm.2010.11.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center